Applicants must submit a mandatory expression of interest prior to 10 September 2019 by completing the online form.
Multimorbidity is recognized as a significant and rapidly increasing health, economic and societal problem in low- middle- and high-income settings. A collective and coordinated effort is required to deliver a step-change in the prevention, measurement, management and treatment of multimorbidity through research.
As part of a framework of activities the Academy of Medical Science (AMS), the National Institute for Health Research (NIHR), the Medical Research Council (MRC, part of UK Research and Innovations) and Wellcome, together with other charities, seek to enable impactful research, build best practice, and provide the evidence needed to tackle the scale of this problem.
This current GCRF global multimorbidity seed-funding call, launched and funded by the MRC, has been developed under this joint multimorbidity funders framework.
The GCRF global multimorbidity seed-funding call is an MRC initiative that has been developed in collaboration with Wellcome, NIHR, and AMS. The call will support seed-funding projects that develop and test innovative ideas, foster interdisciplinary collaboration, build capacity, and lay the groundwork for future large-scale activity aimed at understanding and tackling multimorbidity in LMICs.
Applications are particularly encouraged from Principal Investigators (PIs) based at organisations in LMICs, as well as from eligible research organisations based in the UK working in equitable partnership with LMIC colleagues.
It is expected that a total of £2.5 million will be made available to support research grants up to 18 months in duration and up to a maximum of £200,000.
The research supported through this GCRF call will contribute to the UK’s commitment to Official Development Assistance (ODA) to LMICs. Applications must demonstrate the research to be primarily relevant and directly linked to near-term benefits to the health and/or economic development of LMICs.